Sun Pharma gets US FDA nod for benzonatate
Sun Pharmaceutical Industries Ltd said it has approval from the US Food and Drug Administration to market benzonatate capsules, the generic version of Forest Laboratories' Tessalon.
By PTI |
MUMBAI: Sun Pharmaceutical Industries Ltd said it has approval from the US Food and Drug Administration to market benzonatate capsules, the generic version of Forest Laboratories' Tessalon.
The drug, used to treat cough, common cold, pneumonia and other lung infections, would be available in 100 mg and 200 mg dosages, the firm said in a statement. Benzonatate had annual sales of about $40 million in the United States, Sun said, adding it would start selling the drug shortly.
The drug, used to treat cough, common cold, pneumonia and other lung infections, would be available in 100 mg and 200 mg dosages, the firm said in a statement. Benzonatate had annual sales of about $40 million in the United States, Sun said, adding it would start selling the drug shortly.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
